CDE Detailed Report
Disease: content
Subdomain Name: Neurological Outcomes
CRF: welcome
Displaying 1 - 4 of 4
Subdomain Name: Neurological Outcomes
CRF: welcome
Displaying 1 - 4 of 4
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C11965 | Tardieu Scale movement resistance score | TardieuScaleMovmntResistScore | The semi-quantitative score describing relative resistance to passive limb movement or occurrence of spasticity observed while administering the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject | The semi-quantitative score describing relative resistance to passive limb movement or occurrence of spasticity observed while administering the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subjec | X | 0;1;2;3;4;5 | No resistance throughout the course of the passive movement;Slight resistance throughout the course of passive movement, no clear catch at a precise angle;Clear catch at a precise angle, interrupting the passive movement, followed by release;Fatigable clonus with less than 10 seconds when maintaining the pressure and appearing at the precise angle;Unfatigable clonus with more than 10 seconds when maintaining the pressure and appearing at a precise angle;Joint is immovable (Indicate which assistive device the participant uses) | Numeric Values |
Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs. |
Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62. | Adult;Pediatric | Exploratory | 3.00 | 2013-07-22 16:57:17.79 | Tardieu Scale | Neurological Outcomes | Outcomes and End Points |
Single Pre-Defined Value Selected |
||||||||
| C11966 | Tardieu Scale muscle reaction angle measurement | TardieuScaleMuscReactAngMeasr | The degree of angle for limb position at which muscle reaction or spasticity occurs for a given velocity administered during the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject | The degree of angle for limb position at which muscle reaction or spasticity occurs for a given velocity administered during the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subjec | Y (Degree of angle at which muscle reaction occurs) | Numeric Values |
Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs. |
Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62. | Adult;Pediatric | Exploratory | 3.00 | 2013-07-22 16:57:17.79 | Tardieu Scale | Neurological Outcomes | Outcomes and End Points |
Free-Form Entry |
0 | 180 | degree of arc | |||||||
| C17541 | Tardieu Scale assistive device text | TardieuScaleAssistDevTxt | Text identifying an assistive device used by the participant/subject for an immovable joint in a limb | Text identifying an assistive device used by the participant/subject for an immovable joint in a lim | Indicate which assistive device the participant uses | Alphanumeric | Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62. | Adult;Pediatric | Exploratory | 3.00 | 2013-07-15 16:08:48.687 | Tardieu Scale | Neurological Outcomes | Outcomes and End Points | 255 |
Free-Form Entry |
||||||||||
| C11964 | Tardieu Scale relative velocity rate | TardieuScaleRltvVelocRt | The relative velocity (for a repeated measure) during administration of the Tardieu Scale assessment to measure muscle reaction through evaluation of spasticity and resistance to passive limb movement in a participant/subject | The relative velocity (for a repeated measure) during administration of the Tardieu Scale assessment to measure muscle reaction through evaluation of spasticity and resistance to passive limb movement in a participant/subjec | Velocity | 1;2;3 | V1 - As slow as possible, slower than the natural drop of the limb segment under gravity;V2 - Speed of limb segment falling under gravity;V3 - As fast as possible, faster than the rate of the natural drop of the limb segment under gravity | Numeric Values |
Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs. |
Key Reference:<br />Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.<br />Other References:<br />Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012. <br />Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.<br />Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.<br />Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.<br />Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62. | Adult;Pediatric | Exploratory | 3.00 | 2013-07-22 16:57:17.79 | Tardieu Scale | Neurological Outcomes | Outcomes and End Points |
Single Pre-Defined Value Selected |
